# Wave Life Sciences (WVE) — Earnings

WVE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/wve/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.34 |
| EPS estimate | −$0.30 |
| EPS surprise | −12.40% |
| Revenue surprise | −65.22% |
| Revenue | $2.3M |
| Revenue estimate | $6.5M |
| Reported | Jul 30, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1631574/000119312526324949/wve-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/17438573-6788-9108-505e-785acd93ddf5.html) |

Wave Life Sciences reported Q2 2026 results on July 30, 2026, posting a loss of $0.34 per share. That was 12.40% wider than the $0.30 loss analysts expected and slightly wider than the $0.31 loss in Q2 2025. Revenue was $2.3 million, well below the $6.5 million estimate and down from $8.7 million a year earlier.

Losses are the norm in this record. Only two of the last 20 quarters were profitable: Q3 2023 at $0.07 per share and Q4 2024 at $0.18, which was also the highest revenue quarter in the table at $83.7 million. The annual loss narrowed from $2.13 per share in 2022 to $0.55 in 2023, then widened to $0.78 in 2024 and $1.22 in 2025. Quarterly revenue is uneven: Q1 2026 brought $38.2 million, against $2.3 million in Q2. Wave beat the EPS estimate 7 times in 20 quarters and missed in six of the last eight.

Q3 results arrived between November 9 and November 12 in each of the past five years. That points to around mid-November 2026 for the next report, which will show whether the loss per share stays near the recent $0.30 range.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 30, 2026 | −$0.30 | −$0.34 | -12.40% | $6.5M | $2.3M |
| Q1 2026 | Apr 28, 2026 | −$0.32 | −$0.13 | 59.81% | $8.5M | $38.2M |
| Q4 2025 | Feb 26, 2026 | −$0.27 | −$0.30 | -9.57% | $16.1M | $17.2M |
| Q3 2025 | Nov 10, 2025 | −$0.30 | −$0.32 | -5.19% | $12.6M | $7.6M |
| Q2 2025 | Jul 30, 2025 | −$0.28 | −$0.31 | -11.79% | $13.2M | $8.7M |
| Q1 2025 | May 8, 2025 | −$0.26 | −$0.29 | -11.75% | $11.9M | $9.2M |
| Q4 2024 | Mar 4, 2025 | −$0.18 | $0.18 | 200.67% | $28.7M | $83.7M |
| Q3 2024 | Nov 12, 2024 | −$0.28 | −$0.47 | -66.20% | $16.6M | — |
| Q2 2024 | Aug 8, 2024 | −$0.21 | −$0.25 | -20.54% | $19.5M | $19.7M |
| Q1 2024 | May 9, 2024 | −$0.19 | −$0.24 | -29.03% | $25.0M | $12.5M |
| Q4 2023 | Mar 6, 2024 | −$0.23 | −$0.15 | 33.83% | $19.9M | $29.1M |
| Q3 2023 | Nov 9, 2023 | −$0.18 | $0.07 | 139.26% | $23.4M | $49.2M |
| Q2 2023 | Aug 3, 2023 | −$0.33 | −$0.20 | 39.65% | $7.9M | $22.1M |
| Q1 2023 | May 3, 2023 | −$0.04 | −$0.27 | -575.00% | $32.3M | $12.9M |
| Q4 2022 | Mar 22, 2023 | −$0.41 | −$0.47 | -14.63% | $7.1M | $1.2M |
| Q3 2022 | Nov 10, 2022 | −$0.50 | −$0.42 | 15.44% | $8.2M | $285,000.00 |
| Q2 2022 | Aug 11, 2022 | −$0.51 | −$0.62 | -21.16% | $3.8M | $375,000.00 |
| Q1 2022 | May 12, 2022 | −$0.54 | −$0.62 | -14.52% | $3.9M | $1.8M |
| Q4 2021 | Mar 3, 2022 | −$0.52 | −$0.61 | -16.66% | $15.8M | $1.8M |
| Q3 2021 | Nov 10, 2021 | −$0.60 | −$0.12 | 80.05% | $10.4M | $36.4M |

## Frequently Asked Questions

### When did Wave Life Sciences (WVE) last report earnings?

Wave Life Sciences last reported on Jul 30, 2026, covering fiscal Q2 2026.

### Did WVE beat earnings estimates?

No. Wave Life Sciences reported EPS of −$0.34 for Q2 2026 against a −$0.30 estimate — a 12.40% miss.

### How much revenue did WVE report last quarter?

Wave Life Sciences reported $2.3M in revenue for Q2 2026, against a consensus estimate of $6.5M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).